Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
Tactile Systems targets $360M-$368M in 2026 revenue following 23% growth. Improved Medicare prior authorization processes are driving operational efficiency.
ThredUp targets $351.2M to $356.2M in 2026 revenue with 6.1% EBITDA margins. Success hinges on AI-driven efficiency to offset selective consumer spending trends.
Nifty 50 rose 0.5% to 24,120 as Realty and Pharma led the session. With Laurus Labs eyeing ₹1,300, watch the ₹275 resistance level in natural gas futures.
Palantir projects $7.65B to $7.66B in FY2026 revenue as AI demand grows. Success now hinges on scaling deployment capacity to meet U.S. commercial interest.
Paramount Skydance targets a mid-2026 unified streaming platform launch following 17% revenue growth in Paramount+. Advertising recovery is expected in H2 2026.
Energy markets are pricing in a persistent risk premium as 20M barrels per day remain stranded. We analyze five ASX stocks positioned for this volatility.
InspireMD withdraws 2026 guidance as it pivots to a Q3 2026 FDA approval target for its original CGuard system. Watch for regulatory updates and TCAR outlook.
Sangoma Technologies will report Q3 2026 results on May 13. The call will offer insights into enterprise demand for UCaaS and hybrid communication solutions.
QYLG's covered call strategy faces performance drag as the Nasdaq-100 bull market continues. Understand the trade-off between income and growth potential.
JIADE Limited is raising $12 million via a direct offering at $0.24 per share. The two-tranche structure extends through June 2026, creating a long-term overhang.
The S&P 500 is flat as investors await critical semiconductor earnings. With MSFT and NVDA holding steady, the market looks to AMD for a directional catalyst.
Hedge funds trailed the S&P 500's 10% April surge as defensive positioning limited gains. The performance gap raises questions about institutional risk appetite.
Adeia reported a Q1 revenue beat of $104.8M, marking a 19.6% year-over-year increase. The firm's ability to maintain margins while scaling is the key metric.
3 E Network Technology (MASK) secures $1.3M in convertible notes with an 8% discount. Watch for potential dilution as warrants and debt conversion begin.
Axsome Therapeutics projects $8B in peak sales for Auvelity following an Alzheimer’s agitation approval. The June launch marks a critical commercial test.
Renewed Iran tensions are pressuring US indices, forcing a shift in risk appetite. Monitor key support levels as the market tests its recent record highs.
uniQure reports Q1 2026 earnings on May 5. Watch for updates on hemophilia B commercial progress and cash burn rates to gauge the company's operational runway.
Indian IT faces a critical AI test as FII flight and BoP strain pressure the markets. Monitor banking liquidity and domestic buying to gauge the next move.
Oppenheimer suggests summer weakness in the SPY may be a buying opportunity for a Q4 rally. With an Alpha Score of 39/100, the index faces a mixed outlook.
Portillo’s (PTLO) reports Q1 2026 earnings on May 5 with a consensus EPS of $0.00. Investors are focused on unit-level margins and future expansion plans.
Bicara Therapeutics will report Q1 2026 results on May 11 at 8:30 a.m. ET. Investors are watching for updates on clinical trial progress and cash runway.
Research Frontiers will report Q1 2026 results on May 7. Investors should focus on royalty growth and cash burn to gauge the company's path to profitability.
Pasithea Therapeutics appoints Kartik Krishnan as CMO to drive PAS-004 trials for NF1 tumors. The move signals a shift toward clinical execution for KTTA.
Sensex rose 356 points as state election results met expectations. With Brent crude at USD 109.8, domestic liquidity remains the key buffer against FII selling.
Lancaster Colony missed Q3 revenue estimates by $10.63M, posting $453.4M in sales. The 1% year-over-year decline highlights ongoing margin and volume pressure.
Cabaletta Bio raised $150 million through a 51.7 million share offering priced at $2.90. The move bolsters the company's cash runway for clinical development.
Skycorp Solar shares surged 125% following a deal to acquire Nanjing Cesun Power and secure $3 million in new capital. Watch for integration-led volatility.
Reliance Industries faces near-term pressure as energy segment headwinds offset growth in Jio and retail. Analysts remain cautious on Q4 margin compression.
Robotics ETFs are trailing the 25% surge in broad tech indices like XLK. Structural weightings and liquidity constraints remain the primary hurdles for investors.
Nifty 50 holds at 24,122.15 as banking and telecom stocks drag. Watch the 54,500 support level in Bank Nifty as election results influence afternoon sentiment.